Steve Clayton, head of equity funds, Hargreaves Lansdown: “All eyes are on the Fed today, ahead of the US central bank’s upcoming interest rate-setting meeting where the market is widely…
Steve Clayton, head of equity funds, Hargreaves Lansdown: “Markets have opened higher in the UK and Europe this morning, with the FTSE 100 around 0.2% ahead and European indices similar…
Matt Britzman, senior equity analyst, Hargreaves Lansdown: “The struggle to maintain momentum last week looks set to bleed into early trading on Monday, with the FTSE 100 broadly flat at the open.…
Derren Nathan, head of equity research, Hargreaves Lansdown: “Markets have entered Friday in a positive mood. The FTSE is up taking its cue from Wall Street and eastern exchanges as…
Sophie Lund-Yates, lead equity analyst, Hargreaves Lansdown: “Retail sales have sunk by far more than expected in the UK. There was a highly disappointing 2.3% decline in April, from a…
GSK – Strong first quarter prompts another upgrade Derren Nathan, head of equity research, Hargreaves Lansdown: “GSK has started 2024 in rude health. Strong growth in vaccine and speciality medicines…
Steve Clayton, head of equity funds, Hargreaves Lansdown: “While the UK grappled with its first nationwide Covid-19 lockdown four years ago, Pfizer was winning the race to develop the first…
Steve Clayton, head of equity funds, Hargreaves Lansdown: “A nervous trading session in Asia saw some of yesterday’s euphoria wiped away, ahead of tonight’s rate decision by the US Federal…